Das Asha 4

4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 4, 2020

Insider Transaction Report

Form 4
Period: 2020-03-02
Das Asha
Chief Medical Officer
Transactions
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2020-03-02+82,21482,214 total
    Exercise: $4.77Exp: 2030-03-02Common Stock (82,214 underlying)
Footnotes (1)
  • [F1]3yr 33% On Vest beginning on 02-Mar-2020

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT